These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 20686243)
1. Purpurin as a specific inhibitor of spermidine-induced autoactivation of the protease plasma hyaluronan-binding protein. Nishimura N; Takai M; Yamamoto E; Hasumi K Biol Pharm Bull; 2010; 33(8):1430-3. PubMed ID: 20686243 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of autoactivation of plasma hyaluronan-binding protein (factor VII activating protease). Yamamoto E; Nishimura N; Okada K; Sekido C; Yamamichi S; Hasumi K Biol Pharm Bull; 2011; 34(4):462-70. PubMed ID: 21467630 [TBL] [Abstract][Full Text] [Related]
3. Polyamine-promoted autoactivation of plasma hyaluronan-binding protein. Yamamichi S; Nishitani M; Nishimura N; Matsushita Y; Hasumi K J Thromb Haemost; 2010 Mar; 8(3):559-66. PubMed ID: 19817990 [TBL] [Abstract][Full Text] [Related]
4. Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Yamamichi S; Fujiwara Y; Kikuchi T; Nishitani M; Matsushita Y; Hasumi K Biochem Biophys Res Commun; 2011 Jun; 409(3):483-8. PubMed ID: 21600885 [TBL] [Abstract][Full Text] [Related]
5. Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. Choi-Miura NH; Saito K; Takahashi K; Yoda M; Tomita M Biol Pharm Bull; 2001 Mar; 24(3):221-5. PubMed ID: 11256474 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of plasma hyaluronan-binding protein autoactivation by laccaic acid. Sekido C; Nishimura N; Takai M; Hasumi K Biosci Biotechnol Biochem; 2010; 74(11):2320-2. PubMed ID: 21071862 [TBL] [Abstract][Full Text] [Related]
7. The cyclopentapeptide plactin enhances cellular binding and autoactivation of the serine protease plasma hyaluronan-binding protein. Yamamoto E; Yamamichi S; Choi-Miura NH; Hasumi K Thromb Res; 2010 Nov; 126(5):406-13. PubMed ID: 20864147 [TBL] [Abstract][Full Text] [Related]
8. Elucidation of crucial structures for a catechol-based inhibitor of plasma hyaluronan-binding protein (factor VII activating protease) autoactivation. Yamamoto E; Kitano Y; Hasumi K Biosci Biotechnol Biochem; 2011; 75(10):2070-2. PubMed ID: 21979097 [TBL] [Abstract][Full Text] [Related]
9. Novel human plasma proteins, IHRP (acute phase protein) and PHBP (serine protease), which bind to glycosaminoglycans. Choi-Miura NH Curr Med Chem Cardiovasc Hematol Agents; 2004 Jul; 2(3):239-48. PubMed ID: 15320789 [TBL] [Abstract][Full Text] [Related]
10. Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein. Choi-Miura NH; Takahashi K; Yoda M; Saito K; Mazda T; Tomita M Biol Pharm Bull; 2001 May; 24(5):448-52. PubMed ID: 11379758 [TBL] [Abstract][Full Text] [Related]
11. Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism. Etscheid M; Hunfeld A; König H; Seitz R; Dodt J Biol Chem; 2000 Dec; 381(12):1223-31. PubMed ID: 11209757 [TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. Choi-Miura NH; Tobe T; Sumiya J; Nakano Y; Sano Y; Mazda T; Tomita M J Biochem; 1996 Jun; 119(6):1157-65. PubMed ID: 8827452 [TBL] [Abstract][Full Text] [Related]
13. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747 [TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone. Lee HW; Ryu HW; Kang MG; Park D; Oh SR; Kim H Bioorg Med Chem Lett; 2017 Mar; 27(5):1136-1140. PubMed ID: 28188065 [TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates. Kara E; Manna D; Løset GÅ; Schneider EL; Craik CS; Kanse S Thromb Haemost; 2017 Aug; 117(9):1750-1760. PubMed ID: 28726978 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin. Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470 [TBL] [Abstract][Full Text] [Related]
18. Anthraquinones from Cassiae semen as thrombin inhibitors: in vitro and in silico studies. Yu X; Wei LH; Zhang JK; Chen TR; Jin Q; Wang YN; Zhang SJ; Dou TY; Cao YF; Guo WZ; Ge GB; Yang L Phytochemistry; 2019 Sep; 165():112025. PubMed ID: 31207449 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the plasma hyaluronan-binding protein (PHBP) gene (HABP2). Sumiya J; Asakawa S; Tobe T; Hashimoto K; Saguchi K; Choi-Miura NH; Shimizu Y; Minoshima S; Shimizu N; Tomita M J Biochem; 1997 Nov; 122(5):983-90. PubMed ID: 9443814 [TBL] [Abstract][Full Text] [Related]
20. Identification of the substrates for plasma hyaluronan binding protein. Choi-Miura NH; Yoda M; Saito K; Takahashi K; Tomita M Biol Pharm Bull; 2001 Feb; 24(2):140-3. PubMed ID: 11217080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]